Life Sciences: Corporate/Commercial | USA

Cooley LLP is a much-admired practice with a deep bench of transactional attorneys and a strong Bay Area presence. The firm is recommended for its representation of biotechnology companies in corporate and commercial matters including high-value M&A, venture capital investments and licensing and collaboration agreements. The team fields additional expertise in complex patent litigation, including Hatch-Waxman, infringement and interference cases. The group offers substantial expertise in relation to medical device patent prosecution matters.

Latham & Watkins LLP has a best-in-market corporate team with a sterling reputation for its counsel on M&A transactions, public and private securities offerings, and strategic partnerships. The team acts for early-stage and long-established companies as well as banks and financiers.

Covington & Burling LLP is renowned for the quality of its regulatory compliance counsel, alongside wider expertise in strategic partnerships, collaboration agreements and licensing deals. The group has impressive knowledge of all disciplines within life sciences, including cutting-edge technologies such as digital health and regenerative medicine.

Fenwick offers an admired corporate practice highlighted for its representation of both startup companies and more established entities across the life sciences sector. The firm is particularly noted for assistance with venture capital finance, licensing transactions and strategic partnerships. The group has additional expertise in stock offerings and the treatment of IP assets in high-value M&A transactions and is also noted for the quality of their representation in complex patent disputes.

Gibson, Dunn & Crutcher LLP provides well-regarded corporate counsel with a particularly strong reputation in relation to M&A, financing transactions and strategic collaborations. The group regularly works with significant biotech, pharmaceutical and medical device companies.

The Goodwin team provides experienced corporate counsel for emerging companies with particular expertise in assisting with public and private securities offerings and M&A. The team also receives attention for its counsel on patent portfolio strategies, including licensing deals and due diligence for corporate transactions. They have additional expertise in patent litigation.

Ropes & Gray LLP is a respected life sciences group with broad expertise encompassing contentious and non-contentious mandates. The firm is frequently called upon to represent major companies in acquisitions, financings license and collaboration agreements. It offers notable capabilities advising on regulatory proceedings and litigating complex patent disputes.

DLA Piper LLP houses a highly regarded practice with a strong international presence highlighted for its guidance on the management of IP portfolios and on corporate transactions and stock offerings. The team is also recognized for its contentious work, such as patent disputes and patent office actions. The firm has additional expertise in medical device product liability litigation and corporate governance matters including anti-takeover measures and proxy contests.

Freshfields US LLP is a respected global firm with substantial experience acting for major life sciences companies. The group draws upon the firm's international footprint to advise clients on complex domestic and cross-border transactional work, including M&A, licensing and joint venture agreements.

King & Spalding LLP offers broad life sciences expertise, with deep experience in matters ranging from regulatory approvals to corporate transactions, including investments and financings. The team has strong experience working on cross-border deals.

Paul Hastings LLP is highlighted for its adroit handling of a range of transactional life sciences work. The group regularly represents significant public and private companies on mergers, acquisitions and IPO work.

Perkins Coie LLP represents clients in relation to the management of IP portfolios, including freedom to operate analysis, patent prosecution, due diligence and enforcement actions. The team is also noted for its adept handling of corporate transactions, licensing deals, strategic partnerships and capital markets offerings. The team also assists with PTAB proceedings and advises on FDA compliance matters.

WilmerHale is sought out by companies in the pharmaceutical, medical device, and biotechnology sectors for assistance in commercial transactions. Recognized for experience in strategic alliances, joint ventures, corporate partnerships and licensing, the team's advice also spans venture capital investment strategies, financings and patent infringement litigation.